New biobank aims to unlock prostate cancer secrets in High-Risk genes

This study is building a collection of prostate tissue samples from people who carry certain gene mutations (like BRCA1/2) that raise their risk for aggressive prostate cancer. Researchers will compare these samples with those from people without the mutations to learn how the cancer develops and responds to treatment. The goal is to better understand and eventually improve care for those at highest genetic risk.